Evidence map›Paper›PMID 30186183›Full record

ArticleFrontiers in pharmacology2018

Antidepressant-Like Effects of

Yang Li, Ying Peng, Ping Ma, Hanlin Yang, Haiyan Xiong, Mengyue Wang, Chongsheng Peng, Pengfei Tu, Xiaobo Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Neuropsychiatric disease and treatment · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Frontiers in pharmacology · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Frontiers in nutrition · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Microbiota-Gut-Brain Axis in Major Depression: A New Therapeutic Approach.Advances in experimental medicine and biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yang LiSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Ying PengSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Ping MaSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Hanlin YangSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Haiyan XiongSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Mengyue WangSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Chongsheng PengSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Pengfei TuState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Xiaobo LiSchool of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Jiao Tong University · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing evidence shows that neuropsychiatric disorders, such as depression, are linked with gut microbiome through the gut-brain axis. Cistanches Herba is well known for the treatment of "kidney-yang" deficiency in traditional Chinese medicine (TCM), and has been used for treatment of neurodegenerative diseases in recent years. In this study, chronic unpredictable stress (CUS)-induced depression model was established to explore the impact of

Indexed as

antidepressantchronic unpredictable stressCistanche tubulosagut microbiotamicrobiota–gut–brain axis

Identifiers

PMID30186183
PMCPMC6112285
OpenAlexW2888162511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.